The significant tumor mass increase occurred in response to protumor cellular events, such as fewer CD3+ cells and signaling changes, such as higher IL‐1β levels and lower levels of IL‐12p70, IL‐23 and IFN‐β, in the TME. The gene discussed is IL1B; the disease is neoplasm.